Cargando…
Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study
OBJECTIVE: To evaluate the efficacy and safety of USL255, Qudexy™ XR (topiramate) extended-release capsules, as an adjunctive treatment for refractory partial-onset seizures (POS) in adults taking one to three concomitant antiepileptic drugs. METHODS: In this global phase III study (PREVAIL; NCT0114...
Autores principales: | Chung, Steve S, Fakhoury, Toufic A, Hogan, R Edward, Nagaraddi, Venkatesh N, Blatt, Ilan, Lawson, Balduin, Arnold, Stephan, Anders, Bob, Clark, Annie M, Laine, Dawn, Meadows, R Shawn, Halvorsen, Mark B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143954/ https://www.ncbi.nlm.nih.gov/pubmed/24902983 http://dx.doi.org/10.1111/epi.12660 |
Ejemplares similares
-
USL255 extended-release topiramate: Dose-proportional pharmacokinetics and tolerability in healthy volunteers
por: Clark, Annie M, et al.
Publicado: (2014) -
USLE-Based Assessment of Soil Erosion by Water in the Nyabarongo River Catchment, Rwanda
por: Karamage, Fidele, et al.
Publicado: (2016) -
Locally measured USLE K factor expands sustainable agricultural land in Palau
por: Oda, Masato, et al.
Publicado: (2022) -
Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial
por: Meador, Kimford J., et al.
Publicado: (2016) -
The Arabidopsis USL1 controls multiple aspects of development by affecting late endosome morphology
por: Yuan, Rongrong, et al.
Publicado: (2018)